Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Smit

Showing results (481-490 of 692) with videos related to

Pageof 70
Sort By:
Cancer Chemotherapy and Pharmacology|March 9, 2006
Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancerJ R Kroep, E F Smit, G Giaccone, et al.
BMC Cancer|May 12, 2012
Stepped care targeting psychological distress in head and neck and lung cancer patients: a randomized clinical trialAnne-Marie H Krebber, C René Leemans, Remco de Bree, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patientsM Klein, M J Taphoorn, J J Heimans, et al.
Lung Cancer (Amsterdam, Netherlands)|July 28, 2021
Real-world insights into patients with advanced NSCLC and MET alterationsMarisa Bittoni, James Chih-Hsin Yang, Jin-Yuan Shih, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2019
Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)Rafal Dziadziuszko, Egbert F Smit, Urania Dafni, et al.
British Journal of Cancer|December 4, 2008
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patientsM I Galleges Ruiz, K Floor, S M Steinberg, et al.
Pharmaceutical Research|August 17, 2022
Exposure-Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life SettingRené J Boosman, Merel Jebbink, Wouter B Veldhuis, et al.
Radiation Oncology (London, England)|October 8, 2016
Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancerNaomi E Verstegen, Alexander P W M Maat, Frank J Lagerwaard, et al.
International Journal of Rheumatology|October 12, 2010
Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertensionMaria J Overbeek, Koen T B Mouchaers, Hans M Niessen, et al.
Acta Oncologica (Stockholm, Sweden)|April 30, 2020
Results of neoadjuvant chemo(radio)therapy and resection for stage IIIA non-small cell lung cancer in The NetherlandsPieter J M Joosten, Ronald A M Damhuis, Judi N A van Diessen, et al.
Pageof 70

Showing results (481-490 of 692) with videos related to

Sort By:
Pageof 70
Cancer Chemotherapy and Pharmacology|March 9, 2006
Pharmacology of the paclitaxel-cisplatin, gemcitabine-cisplatin, and paclitaxel-gemcitabine combinations in patients with advanced non-small cell lung cancerJ R Kroep, E F Smit, G Giaccone, et al.
BMC Cancer|May 12, 2012
Stepped care targeting psychological distress in head and neck and lung cancer patients: a randomized clinical trialAnne-Marie H Krebber, C René Leemans, Remco de Bree, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Neurobehavioral status and health-related quality of life in newly diagnosed high-grade glioma patientsM Klein, M J Taphoorn, J J Heimans, et al.
Lung Cancer (Amsterdam, Netherlands)|July 28, 2021
Real-world insights into patients with advanced NSCLC and MET alterationsMarisa Bittoni, James Chih-Hsin Yang, Jin-Yuan Shih, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 3, 2019
Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)Rafal Dziadziuszko, Egbert F Smit, Urania Dafni, et al.
British Journal of Cancer|December 4, 2008
Combined assessment of EGFR pathway-related molecular markers and prognosis of NSCLC patientsM I Galleges Ruiz, K Floor, S M Steinberg, et al.
Pharmaceutical Research|August 17, 2022
Exposure-Response Analysis of Osimertinib in EGFR Mutation Positive Non-Small Cell Lung Cancer Patients in a Real-Life SettingRené J Boosman, Merel Jebbink, Wouter B Veldhuis, et al.
Radiation Oncology (London, England)|October 8, 2016
Salvage surgery for local failures after stereotactic ablative radiotherapy for early stage non-small cell lung cancerNaomi E Verstegen, Alexander P W M Maat, Frank J Lagerwaard, et al.
International Journal of Rheumatology|October 12, 2010
Characteristics of interstitial fibrosis and inflammatory cell infiltration in right ventricles of systemic sclerosis-associated pulmonary arterial hypertensionMaria J Overbeek, Koen T B Mouchaers, Hans M Niessen, et al.
Acta Oncologica (Stockholm, Sweden)|April 30, 2020
Results of neoadjuvant chemo(radio)therapy and resection for stage IIIA non-small cell lung cancer in The NetherlandsPieter J M Joosten, Ronald A M Damhuis, Judi N A van Diessen, et al.
Pageof 70